ACR 2022 Tweet by Eric Dein

Tweet
Eric Dein @ericdeinmd Nov 13, 2022
View on
Year in Review #ACR22
GLORIA
Low steroid usage: lower DAS28, reduced joint damage
BUT 24% increased adverse effects
⁦@RheumNow⁩
Image from Eric Dein’s tweet

Related Content

Podcast

DERM on RheumNow PODCAST (September 2026)

RheumNow Sep 30, 2026
The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, calcinosis, CTD skin disorders. dermatology drugs, biologics, and JAK inhibitors. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: FDA Grants Priority…
Article Education/ACR/EULAR

Steroids

Jack Cush, MD Apr 28, 2026
In this Advanced Practice Rheum, Dr. Jack Cush reviews steroids.
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×